Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Bullboard Posts
Post by Ride_The_Hype2on Feb 18, 2012 1:43am
350 Views
Post# 19553337

Copper One agreement for Quebec claims

Copper One agreement for Quebec claims

2012-02-17 16:11 ET - Property Agreement

 

Also Property Agreement (C-ADK) Diagnos Inc (2)

 

The TSX Venture Exchange has accepted for filing a mineral property purchase and sale agreement dated Feb. 8, 2012, between Copper One Inc. and Diagnos Inc., whereby Copper One may acquire a 100-per-cent interest in 56 mineral claims in the Obalski and Oueylus townships near the town of Chibougamau, Que. In consideration, the company will pay $10,000 in cash and issue to Diagnos 175,000 common shares.

Bullboard Posts